He et al. found that miR-16 suppressed carcinogenesis and progression of nasopharyngeal carcinoma via targeting fibroblast growth factor 2(FGF2), inactivating the PI3K/AKT and MAPK signaling pathways [22]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.